Glyceryl trinitrate for the treatment of preterm labor

ArticleAçık Erişim

Özet

Objective: This study was conducted to compare the tocolytic efficacy of glyceryltrinitrate (GTN) with that of magnesium sulfate (MgSO4) and to investigate serum nitric oxide metabolites before and after tocolysis. Material and Methods: In total, 48 women between 27 and 34 weeks’ gestation with threatened preterm labor and intact membranes were randomly allocated to receive either GTN or MgSO4 tocolysis. Main outcome measures included tocolytic efficacy and maternal side effect(s) of the tocolytic agent. Obstetric and neonatal outcomes as well as pretreatment and posttreatment nitric oxide (NO) metabolites were assessed. Results: Forty-one patients were included into the final analysis. Uterine contraction cessation times were 3.66±1.28 and 6.83±3.47 hours for GTN and MgSO4 groups, respectively. Similarly, maternal side effects were significantly lower in the GTN group than in the MgSO4 group, and no serious maternal side effects were recorded. Serum NO metabolite levels before treatment were significantly lower in the treatment groups than in the controls. Serum nitrite levels were significantly increased after tocolytic treatment both in MgSO4 and GTN groups. Conclusion: GTN effectively delays preterm delivery and reduces neonatal morbidity and mortality with less maternal side effects and seems to be an effective and safe alternative to MgSO4. © 2015 by the Turkish-German Gynecological Education and Research Foundation.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/15163Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.5152/jtgga.2015.15016Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorÇalışkan, Şafak
dc.contributor.authorNarin, Mehmet Ali
dc.contributor.authorDede, Faruk Suat
dc.contributor.authorNarin, Raziye
dc.contributor.authorDede, Hülya
dc.contributor.authorKandemir, Ömer
dc.date.accessioned2026-10-18T20:29:57.299206546Z
dc.date.available2026-10-18T20:29:57.299206546Z
dc.date.issued2015
dc.description.abstractObjective: This study was conducted to compare the tocolytic efficacy of glyceryltrinitrate (GTN) with that of magnesium sulfate (MgSO4) and to investigate serum nitric oxide metabolites before and after tocolysis. Material and Methods: In total, 48 women between 27 and 34 weeks’ gestation with threatened preterm labor and intact membranes were randomly allocated to receive either GTN or MgSO4 tocolysis. Main outcome measures included tocolytic efficacy and maternal side effect(s) of the tocolytic agent. Obstetric and neonatal outcomes as well as pretreatment and posttreatment nitric oxide (NO) metabolites were assessed. Results: Forty-one patients were included into the final analysis. Uterine contraction cessation times were 3.66±1.28 and 6.83±3.47 hours for GTN and MgSO4 groups, respectively. Similarly, maternal side effects were significantly lower in the GTN group than in the MgSO4 group, and no serious maternal side effects were recorded. Serum NO metabolite levels before treatment were significantly lower in the treatment groups than in the controls. Serum nitrite levels were significantly increased after tocolytic treatment both in MgSO4 and GTN groups. Conclusion: GTN effectively delays preterm delivery and reduces neonatal morbidity and mortality with less maternal side effects and seems to be an effective and safe alternative to MgSO4. © 2015 by the Turkish-German Gynecological Education and Research Foundation.
dc.identifier.doi10.5152/jtgga.2015.15016
dc.identifier.eissn1309-0380
dc.identifier.endpage178
dc.identifier.issn1309-0399
dc.identifier.issue3
dc.identifier.pmcidPMC4560476
dc.identifier.pmid26401112
dc.identifier.scopus2-s2.0-84940210129
dc.identifier.startpage174
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/15163
dc.identifier.volume16
dc.identifier.wosWOS:000360154900009
dc.language.isoen
dc.publisherAVES
dc.relation.ispartofJournal of the Turkish German Gynecology Association
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectGlyceryl trinitrate
dc.subjectMagnesium sulfate
dc.subjectNitric oxide
dc.subjectTocolysis
dc.subjectbetamethasone acetate plus betamethasone sodium phosphate
dc.subjectdiazepam
dc.subjectparacetamol
dc.subjectadult
dc.subjectArticle
dc.subjectbody temperature disorder
dc.subjectclinical article
dc.subjectclinical effectiveness
dc.subjectcontrolled study
dc.subjectdizziness
dc.subjectdrug safety
dc.subjectfemale
dc.subjectgestation period
dc.subjectheadache
dc.subjectheart palpitation
dc.subjecthuman
dc.subjectloading drug dose
dc.subjectnausea
dc.subjectnewborn morbidity
dc.subjectnewborn mortality
dc.subjectoutcome assessment
dc.subjectpregnancy outcome
dc.subjectpremature labor
dc.subjectprospective study
dc.subjectprotein blood level
dc.subjectrandomized controlled trial
dc.titleGlyceryl trinitrate for the treatment of preterm labor
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus3
rdl.citation.wos2
rdl.departmentDepartment of Obstetrics and Gynecology, Erzincan University Faculty of Medicine, Erzincan, Turkey.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexEmerging Sources Citation Index (ESCI)